1. Home
  2. SILO vs HOFV Comparison

SILO vs HOFV Comparison

Compare SILO & HOFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • HOFV
  • Stock Information
  • Founded
  • SILO 2010
  • HOFV 2015
  • Country
  • SILO United States
  • HOFV United States
  • Employees
  • SILO N/A
  • HOFV N/A
  • Industry
  • SILO Apparel
  • HOFV Services-Misc. Amusement & Recreation
  • Sector
  • SILO Consumer Discretionary
  • HOFV Consumer Discretionary
  • Exchange
  • SILO Nasdaq
  • HOFV Nasdaq
  • Market Cap
  • SILO 8.8M
  • HOFV 8.2M
  • IPO Year
  • SILO N/A
  • HOFV N/A
  • Fundamental
  • Price
  • SILO $1.42
  • HOFV $1.18
  • Analyst Decision
  • SILO
  • HOFV Hold
  • Analyst Count
  • SILO 0
  • HOFV 1
  • Target Price
  • SILO N/A
  • HOFV N/A
  • AVG Volume (30 Days)
  • SILO 309.4K
  • HOFV 17.9K
  • Earning Date
  • SILO 02-25-2025
  • HOFV 03-19-2025
  • Dividend Yield
  • SILO N/A
  • HOFV N/A
  • EPS Growth
  • SILO N/A
  • HOFV N/A
  • EPS
  • SILO N/A
  • HOFV N/A
  • Revenue
  • SILO $72,102.00
  • HOFV $22,529,744.00
  • Revenue This Year
  • SILO $1.86
  • HOFV N/A
  • Revenue Next Year
  • SILO N/A
  • HOFV $10.19
  • P/E Ratio
  • SILO N/A
  • HOFV N/A
  • Revenue Growth
  • SILO N/A
  • HOFV 7.02
  • 52 Week Low
  • SILO $0.77
  • HOFV $0.81
  • 52 Week High
  • SILO $4.50
  • HOFV $3.78
  • Technical
  • Relative Strength Index (RSI)
  • SILO 42.07
  • HOFV 49.27
  • Support Level
  • SILO $1.42
  • HOFV $1.11
  • Resistance Level
  • SILO $1.57
  • HOFV $1.29
  • Average True Range (ATR)
  • SILO 0.17
  • HOFV 0.10
  • MACD
  • SILO -0.07
  • HOFV -0.01
  • Stochastic Oscillator
  • SILO 2.82
  • HOFV 30.53

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About HOFV Hall of Fame Resort & Entertainment Company

Hall Of Fame Resort & Entertainment Co operates as a holding company. The firm is a sports, entertainment, and media company. It generates revenues from various streams such as sponsorship agreements, rents, cost recoveries, events, hotel operations, Hall of Fantasy League, and through the sale of media assets.

Share on Social Networks: